NCT05078138View on ClinicalTrials.gov

Impact of Erythropoietin on Hematological Adaptations and Physical Performance

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Exercise-Induced AnemiaPhysical Performance
Interventions
DRUG

Epoetin Alfa

Subcutaneous injection of Epoetin Alfa 3 times per week for 4 weeks

Trial Locations (1)

01760

US Army Research Institute of Environmental Medicine, Natick

All Listed Sponsors
lead

United States Army Research Institute of Environmental Medicine

FED

NCT05078138 - Impact of Erythropoietin on Hematological Adaptations and Physical Performance | Biotech Hunter | Biotech Hunter